Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Burza, Maria Antonella ^a   Romeo, Stefano ^a,b   Kotronen, Anna ^c   Svensson, Per Arne ^a   Sjöholm, Kajsa ^a   Torgerson, Jarl S ^d   Lindroos, Anna Karin ^e   Sjöström, Lars ^a   Carlsson, Lena M S ^a   Peltonen, Markku ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Regional Secretariat   (Sweden)

^e NATIONAL FOOD ADMINISTRATION   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PROSPECTIVE STUDY; REMISSION; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BODY WEIGHT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; SWEDEN; TIME; TRANSAMINASES;

EID: 84875436214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060495     Document Type: Article

References (23)

1. Clark JM, Brancati FL, Diehl AM, (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98: 960-967.
2. Torgerson JS, Lindroos AK, Sjöström CD, Olsson R, Lissner L, et al. (1997) Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res 5: 105-114.
3. Wanless IR, Lentz JS, (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12: 1106-1110.
4. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, et al. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121.
5. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, et al. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44: 865-873.
6. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, et al. (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693.
7. Dixon JB, Bhathal PS, O'Brien PE, (2006) Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 16: 1278-1286.
8. Del Genio F, Del Genio G, De Sio I, Marra M, Alfonsi L, et al. (2009) Noninvasive evaluation of abdominal fat and liver changes following progressive weight loss in severely obese patients treated with laparoscopic gastric bypass. Obes Surg 19: 1664-1671.
9. Silvestre V, Ruano M, Domínguez Y, Castro R, García-Lescun MC, et al. (2004) Morbid obesity and gastric bypass surgery: biochemical profile. Obes Surg 14: 1227-1232.
10. Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, et al. (2005) Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 15: 1154-1160.
11. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, et al. (2009) Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137: 532-540.
12. Wolf AM, Beisiegel U, (2007) The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients. Obes Surg 17: 910-919.
13. Mathurin P, Gonzalez F, Kerdraon O, Leteurtre E, Arnalsteen L, et al. (2006) The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 130: 1617-1624.
14. Johansson HE, Haenni A, Ohrvall M, Sundbom M, Zethelius B, (2009) Alterations in proinsulin and insulin dynamics, HDL Cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study. Obes Surg 19: 601-607.
15. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, et al. (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87: 3555-3561.
16. Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, et al. (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev: CD007340.
17. Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, et al. (1992) Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 16: 465-479.
18. Lindroos AK, Lissner L, Sjöström L, (1993) Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects. Eur J Clin Nutr 47: 461-481.
19. Kotronen A, Yki-Järvinen H, Männistö S, Saarikoski L, Korpi-Hyövälti E, et al. (2010) Non-alcoholic and alcoholic fatty liver disease- two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health 10: 237.
20. Angulo P, Keach JC, Batts KP, Lindor KD, (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362.
21. StataCorp: Stata Statistical Software. Release 9.0. College Station, TX: StataCorp LP 2005.
22. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, et al. (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357: 741-752.
23. Siest G, Schiele F, Galteau MM, Panek E, Steinmetz J, et al. (1975) Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem 21: 1077-1087.